Abstract
Epidermal growth factor receptor (EGFR) overexpression has been associated frequently with squamous cell carcinomas (SCC) and SCC cell lines. In most cases the level of EGFR on the tumours from which the cell lines were derived has not been determined, nor have EGFR levels been determined for xenograft tumours from the cell lines. In this study we determined EGFR expression on a new series of head and neck SCC (SCCHN)-derived cell lines, which were obtained from tumours representing a spectrum of malignant progression, and two cell strains derived from erythroplakia premalignant lesions. The level of EGFR on cell lines was determined by [125I]EGF competitive binding assays. EGFR levels on some of the original tumours and xenografts of the cell lines were determined on cryosections by a competitive binding assay based on [125I]EGFR1, an EGFR-specific monoclonal antibody. EGFR expression on the tumour cryosections was compared with expression on cryosections of skin and buccal mucosa. Eight of the ten tumour cell lines had elevated EGFR. Two of the tumour-derived cell lines and the two erythroplakia-derived cell strains expressed EGFR at levels similar to that detected on normal keratinocytes in tissue culture. Only two of the tumours overexpressed EGFR when compared with normal tissue. The other tumours had levels similar to that detected on the basal layers of skin or buccal mucosa. The xenografts expressed EGFR, as did the original tumours, even though they were derived from cell lines that displayed significant overexpression of EGFR. This study suggests that most tumours have a latent potential to overexpress EGFR which is realised in tissue culture.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stanton, P., Richards, S., Reeves, J. et al. Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts. Br J Cancer 70, 427–433 (1994). https://doi.org/10.1038/bjc.1994.322
Issue Date:
DOI: https://doi.org/10.1038/bjc.1994.322
This article is cited by
-
Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance
World Journal of Surgical Oncology (2019)
-
Human squamous cell carcinomas lose a mortality gene from chromosome 6q14.3 to q15
Oncogene (2003)
-
The role of epidermal growth factor receptor in head and neck squamous cell carcinoma
Current Oncology Reports (2003)
-
Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4
Oncogene (2002)
-
Differences of reactivity to interferon ? in HeLa and CaSki cells: a combined immunocytochemical and flow-cytometric study
Journal of Cancer Research and Clinical Oncology (1996)